Litcius/Paper detail

The Glucagon‐Like Peptide‐1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis

Laura E. Dichtel

2021Hepatology19 citationsDOIOpen Access PDF

Topics & Concepts

Nonalcoholic steatohepatitisMedicineInternal medicineExenatideSemaglutideHepatologyLixisenatideLibrary scienceFamily medicineEndocrinologyNonalcoholic fatty liver diseaseDiabetes mellitusLiraglutideType 2 diabetesComputer scienceFatty liverDiseaseDiabetes Treatment and ManagementPancreatic function and diabetesPancreatitis Pathology and Treatment
The Glucagon‐Like Peptide‐1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis | Litcius